Injectable treatment to reduce belly fat
Treatments studied
This study tests a new injectable treatment, CBL-514, to reduce belly fat. It may help people who have stubborn abdominal fat that doesn't go away with diet and exercise.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You weigh at least 50 kg (about 110 lbs) and have a BMI between 18.5 and 30.
- You have moderate to severe belly fat that you are unhappy with.
- Your weight has been steady recently.
- You are not currently taking weight-loss medication (including injections like Ozempic).
- You are willing to follow the study rules and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called CBL-514 that is designed to reduce fat under the skin in the belly area. It might help people who are dissatisfied with stubborn abdominal fat that doesn't go away with diet and exercise.
This study checks whether the fat-reducing effects from the earlier treatment last over time, and whether the treatment is safe to use long-term. It is only for people who already took part in the first part of this study.
This study tests whether CBL-514, an injection given under the skin, can safely reduce stubborn belly fat in people with normal to slightly elevated weight. Researchers will measure changes in abdominal fat using imaging and patient assessments.
This study tests an injection called CBL-514 that may help reduce belly fat. It is for adults with extra abdominal fat who want a non-surgical option.
This trial tests a new non-invasive device to reduce fat in the belly and sides (love handles). It may help people who have stubborn fat in these areas despite a stable weight.
This study tests an injected medication called ABBV-295 for adults with obesity. The goal is to see how safe it is and how the body processes it. You may join if you have a BMI between 30 and 45 and are generally healthy, and you haven't been on other weight loss treatments recently.
Hear when a new Subcutaneous Fat trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.